Stock listing
LX31 Stock Price, News, Filings & Events — Lexicon Pharmaceuticals, Inc.
Selected listing: LX31 · TRADEGATE · EUR · DE
LX31:TRADEGATE is the listing for Lexicon Pharmaceuticals, Inc., a company dedicated to developing innovative therapies for various diseases. With a market capitalization of approximately $1.06 billion, Lexicon utilizes its proprietary technology platform to advance its pipeline of drug candidates. The company is focused on addressing unmet medical needs, and its ongoing developments and filings are closely monitored by investors and industry analysts. Recent news and events related to Lexicon may impact its market presence and investor interest.
- Ticker
- LX31:TRADEGATE
- Asset type
- Stock
- Market cap
- $1.02B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TRADEGATE
- Currency
- EUR
Lexicon Pharmaceuticals, Inc. LX31:TRADEGATE stock context
LX31:TRADEGATE is the listing for Lexicon Pharmaceuticals, Inc., a company dedicated to developing innovative therapies for various diseases. With a market capitalization of approximately $1.06 billion, Lexicon utilizes its proprietary technology platform to advance its pipeline of drug candidates. The company is focused on addressing unmet medical needs, and its ongoing developments and filings are closely monitored by investors and industry analysts. Recent news and events related to Lexicon may impact its market presence and investor interest.
Research Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. investor report
Review AI stock analysis and investor report context for LX31:TRADEGATE.
Lexicon Pharmaceuticals, Inc. company profile
View the public company page for Lexicon Pharmaceuticals, Inc. on 6ix.
Lexicon Pharmaceuticals, Inc. news
Read company news and market updates connected to Lexicon Pharmaceuticals, Inc..
Lexicon Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Lexicon Pharmaceuticals, Inc..